FiercePharma's 2007 trends & 2008 predictions

Take a look at FiercePharma's 2007 year-end round-up and our predictions for the year ahead.  

2007 pharma industry trends:

1. The specter of generic competition grows 

2. New CEOs march to the top 

3. Pharma layoffs set new record

4. Pharma goes mad for biotech deals

5. FDA: Hyper-cautious or simply vigilant?


2008 Predictions:

1. Wanted: Rugged pharmas for tough trip

2. FDA reforms lack cash backup

3. Pharma noshes at the biotech buffet

4. Pharma feeds contract manufacturing

5. Blockbusters on their way to generic-land

ALSO: Check out the list of FiercePharma's most-read articles of 2007. Report

FiercePharma's 2007 trends & 2008 predictions
Read more on

Suggested Articles

Teva is reportedly going for a moonshot with a $15 billion drug offer to settle its opioid cases. It's a plan that might just work, one analyst said.

CSL has sued a former exec who its says stole thousands of key documents as he left for competitor Pharming.

Influential U.S. cost watchdog ICER gave its blessing to Johnson & Johnson and Amarin's CV drugs. But there's a big catch for both meds.